anticancer agents (ED Laboratories)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameanticancer agents (ED Laboratories)
Drug Alias Nameanticancer agents (ED Laboratories)EDL-360EDL-155
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinoblastomaGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesED Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesED Laboratories Inc
Active IndicationsN/A
Inactive IndicationsRetinoblastomaGlioblastomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A